Your browser doesn't support javascript.
loading
The Risk of Hepatitis B Virus Reactivation in HBsAg-Negative and Anti-HBc-Positive Patients Receiving Tumor Necrosis Factor Antagonists.
Ozaras, Resat; Ozaras, Nihal; Demirel, Aslihan.
Affiliation
  • Ozaras R; Infection Department, Medilife Hospital, Istanbul, Turkey.
  • Ozaras N; Physical Medicine and Rehabilitation Department, Avrasya Hospital.
  • Demirel A; Infection Department, Bilim University.
Clin Gastroenterol Hepatol ; 17(1): 210, 2019 01.
Article in En | MEDLINE | ID: mdl-30558892
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B virus / Chemical and Drug Induced Liver Injury Type of study: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2019 Document type: Article Affiliation country: Turkey
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B virus / Chemical and Drug Induced Liver Injury Type of study: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2019 Document type: Article Affiliation country: Turkey